A Meta-Analysis of the Efficacy of Cefaclor in Lower Respiratory Tract Infection

References

• Huchon GJ, Gialdroni-Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infections in the community: a European survey. Eur Resp J 1996; 9:1590-5
   Google Scholar
• L’Abbé K, Detsky AS, O’Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987; 107: 224-233.
   Google Scholar
• Chalmers TC, Smith H, Blackburn B, et al. A method for assessing the quality of a randomized control trial. Control Clin Trials 1981; 2: 31-49.
   Google Scholar
• Armitage P, Berry G. Statistical methods in epidemiology. In: Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell Scientific Publications, 1987; Chapter 16, 459-464.
   Google Scholar
• Breslow NE, Day NE. Classical methods of analysis of grouped data. In: Statistical Methods in Cancer Research, Volume 1, The analysis of case-control studies. Lyon: International Agency for Research on Cancer Scientific Publications No. 32, 1980, Chap IV, 139-140.
   Google Scholar
• Klein S, Simes J, Blackburn GL. Total parenteral nutrition and cancer clinical trials. Cancer 1986; 58: 1378-86.
   Google Scholar
• Barsic B, Schonwald S, Klinar I, Sagud M, Suskovic T. Comparison of three-day azithromycin and ten-day cefaclor in the treatment of patients with bacterial lower respiratory tract infection. Pharmaca 1994; 32: 137-146.
   Google Scholar
• Fujimori I, Kobayashi Y, Obana M, et al. Comparative clinical study of ofloxacin and cefaclor in bacterial bronchitis. Kansenshogaku Zasshi 1984; 58: 832-861.
   Google Scholar
• Gotfried MH, Ellison WT. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis. Am J Med 1992; 92A: 108-113
   Google Scholar
• Kobayashi H, Takamura K, Takeda H, et al. Comparative clinical study of ciprofloxacin and cefaclor in the treatment of respiratory tract infections. Chemotherapy 1986; 34: 1011-1037.
   Google Scholar
• Kobayashi H, Kawai S, Saito A, et al. Comparative clinical study of T-2588 and cefaclor in chronic respiratory tract infections by a double-blind method. (In Japanese) Kansenshogaku Zasshi 1986; 60: 1052-1077.
   Google Scholar
• Quenzer RW, Davis RL, Neidhart MM. Prospective randomized study comparing the efficacy and safety of ciprofloxacin with cefaclor in the treatment of patients with purulent bronchitis. Diagn Microbiol Infect Dis 1990; 13: 143-148.
   Google Scholar
• Shimada K, Sano Y, Miyamoto Y, et al. Comparative study on the efficacy of lomefloxacin (NY-198) and cefaclor in respiratory tract infections. Chemotherapy 1989; 37: 616-645.
   Google Scholar
• Dark DS, Farber M, Rice K, et al. Oral ofloxacin versus cefaclor for LRTIs in adults. Infect Med 1995; 12: 551-556.
   Google Scholar
• Kosmidis J. A double blind study of once daily temafloxacin in the treatment of bacterial lower respiratory tract infections. J Antimicrob Chemother 1991; 28, Suppl C: 73-79.
   Google Scholar
• Lindsay G, Scorer HJN, Carnegie CMD. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial. J Antimicrob Chemother 1992; 30: 89-100.
   Google Scholar
• Ball AP, Tillotson GS. Lower respiratory tract infection therapy - the role of ciprofloxacin. J Internat Med Res 1995; 23: 315-327.
   Google Scholar
• Khajotia RR, Vetter N, Harazin H. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective comparative trial. Clin Ther 1991; 13: 460-466.
   Google Scholar
• Dark D. Azithromycin versus cefaclor in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Curr Ther Res - Clin Exp 1993; 53: 203-211.
   Google Scholar
• Kinasewitz G, Wood RG. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. Eur J Clin Microbiol Infect Dis 1991; 10: 872-877.
   Google Scholar
• Hoepelman IM, Mollers MJ, van Schie MH, et al. A short (3-day) course of azithromycin tablets versus a 10 day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome. Int J Antimicrob Agents 1997; 9: 141-6.
   Google Scholar
• Zachariah J. A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections. J Antimicrob Chemother 1996; 37 Suppl C: 103-113.
   Google Scholar
• Turik MA, Johns D. Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy. J Chemother 1998; 10: 306-312.
   Google Scholar
• Drehobl M, Bianchi P, Keyserling CH, Tack KJ, Griffin TJ. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia. Antimicrob Agents Chemother 1997; 41: 1579-1583.
   Google Scholar
• Green JA, Butler T, Mark Todd W. Randomized double-blind trial of the comparative efficacy and safety of cefpodoxime proxetil and cefaclor in the treatment of acute community-acquired pneumonia. Curr Ther Res - Clin Exp 1994; 55: 1003-1015.
   Google Scholar
• Poole JM, Rosenberg R, Aronovitz GH, et al. Cefprozil vs. cefixime and cefaclor in otitis media in children. Infect Med 1992; 9 suppl E: 21-32.
   Google Scholar
• Casali L, Voi M, Janssen CJ, Olovich KG, Dere WH. Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia. Clin Ther 1992; 14: 570-577.
   Google Scholar

• Anderson G, Williams L, Pardoe T, Peel ET. Co-trimoxazole versus cefaclor in acute on chronic bronchitis. J Antimicrob Chemother 1981; 8: 487-489.
   Google Scholar
• Barsic B, Schonwald S, Klinar I, Sagud M, Suskovic T. Comparison of three-day azithromycin and ten-day cefaclor in the treatment of patients with bacterial lower respiratory tract infection. Pharmaca 1994; 32: 137-146.
   Google Scholar
• Beumer HM, Veldkamp J. Oral cefaclor for treatment of bronchitis - a comparative double-blind study versus amoxycillin. Int J Clin Pharmacol Ther Toxicol 1982; 20: 113-117.
   Google Scholar
• Boschi G, Zanacca C, Bartoli G, et al. Cefaclor vs amoxicillin and clavulanic acid in respiratory infections in paediatric age. <Cefaclor vs amoxicillina + acido clavulanico nelle infezioni respiratorie in eta pediatrica.> Gazzetta Medica Italiana Archivio per le Scienze Mediche 1992; 151: 11-15.
   Google Scholar
• Casali L, Voi M, Janssen CJ, Olovich KG, Dere WH. Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia. Clin Ther 1992; 14: 570-577.
   Google Scholar
• Chidiac C. Cefaclor in the treatment of bronchitis. <Cefaclor dans le traitement des bronchites.> Med Mal Infect 1994; 24: 4-11.
   Google Scholar
• Chirurgi VA, Edelstein H, Oster SE, et al. Ceftibuten versus cefaclor for the treatment of bronchitis. J Antimicrob Chemother 1991; 28: 577-580.
   Google Scholar
• Christensson B, Nilsson-Ehle I, Ljungberg B, et al. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with respiratory infection. Infection 1991; 19: 208-215.
   Google Scholar
• Dark D. Azithromycin versus cefaclor in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Curr Ther Res - Clin Exp 1993; 53: 203-211.
   Google Scholar
• Dark DS, Farber M, Rice K, et al. Oral ofloxacin versus cefaclor for LRTIs in adults. Infect Med 1995; 12: 551-556.
   Google Scholar
• Dere WH, Farlow D, Therasse DG, Ruoff GE. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis. Clin Ther 1992; 14: 41-53.
   Google Scholar
• Dorow P. Safety and efficacy of cefixime versus cefaclor in respiratory tract infections. J Chemother 1989; 1: 257-260.
   Google Scholar
• Drehobl M, Bianchi P, Keyserling CH, Tack KJ, Griffin TJ. Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia. Antimicrob Agents Chemother 1997; 41: 1579-1583.
   Google Scholar
• Ellis-Pegler RB, West SR. Cefaclor v amoxycillin in acute exacerbations of chronic bronchitis. New Zealand Med J 1982; 95: 201-202.
   Google Scholar
• Faris Jr HM. Cefaclor versus amoxicillin in the treatment of bacterial bronchitis. Curr Ther Res - Clin Exp 1989; 45: 914-917.
   Google Scholar
• Fong IW, Laforge J, Dubois J, Small D, Grossman R, Zakhari R. Clarithromycin versus cefaclor in lower respiratory tract infections. Clin Invest Med 1995; 18: 131-138.
   Google Scholar
• Fujimori I, Kobayashi Y, Obana M, Saito A, Tomizawa M, Nakayama I, et al. Comparative clinical study of ofloxacin and cefaclor in bacterial bronchitis. (In Japanese) Kansenshogaku Zasshi 1984; 58: 832-861.
   Google Scholar
• Gaillat J, Leroyer C, Leduc D, et al. Cefaclor versus amoxicillin-clavulanic acid for treatment of chronic bronchitis acute exacerbations. <Cefaclor versus amoxicilline-acide clavulanique au cours des poussees de surinfection de bronchite chronique.> Med Mal Infect 1994; 24: 29-35.
   Google Scholar
• Gotfried MH, Ellison WT. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis. Am J Med 1992; 92A: 108-113.
   Google Scholar
• Grassi GG, Norrby SR, Neu HC, Aquino. Comparative clinical efficacy of cefetamet pivoxil in lower respiratory tract infection. Drugs 1994; 47 suppl. 3: 35-42.
   Google Scholar
• Green JA, Butler T, Mark Todd W. Randomized doubleblind trial of the comparative efficacy and safety of cefpodoxime proxetil and cefaclor in the treatment of acute community-acquired pneumonia. Curr Ther Res - Clin Exp 1994; 55: 1003-1015.
   Google Scholar
• Grossman RF. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis. Postgrad Med J 1992; 68 suppl 3: 30-37.
   Google Scholar
• Guay DRP, Siepman N, Tanaka SK, Devcich K, Carl Craft J. Comparative safety and efficacy of clarithromycin and 3 oral cephalosporins in the treatment of outpatients with bacterial bronchitis due to Haemophilus influenza. Drug Invest 1993; 6: 33-41.
   Google Scholar
• Hara K, Hirota M, Kohno S, et al. Double-blind comparative study on cefdinir and cefaclor in bacterial pneumonia. Chemotherapy 1989; 37 suppl 2: 634-659.
   Google Scholar
• Hara K, Hirota M, Kohno S, et al. Double-blind comparative study on TE-031 (clarithromycin) and cefaclor (CCL) in treatment of chronic respiratory tract infections. Chemotherapy 1989; 37: 314-335.
   Google Scholar
• Hiraga Y, Kikuchi K, Yamamoto A. Clinical studies of cefaclor for respiratory tract infections. Jpn J Antibiot 1984; 37: 581-588.
   Google Scholar
• Hurst DJ. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis. Clin Ther 1984; 6: 163-169.
   Google Scholar
• Jaffe GV, Grimshaw JJ. Comparative study of cefaclor and amoxycillin in the treatment of respiratory tract infections in general practice. Curr Med Res Opin 1980; 6: 569-572.
   Google Scholar
• Kammer RB, Ress R. Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infections. Diagn Microbiol Infect Dis 1991; 14: 101-105.
   Google Scholar
• Kinasewitz G, Wood RG. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. Eur J Clin Microbiol Infect Dis 1991; 10: 872-877.
   Google Scholar
• Kissling M. Cefetamet pivoxil in community-acquired pneumonia: an overview. Curr Med Res Opin 1992; 12: 631-639.
   Google Scholar
• Kobayashi H, Kawai S, Saito A, et al. Comparative clinical study of T-2588 and cefaclor in chronic respiratory tract infections by a double-blind method. (In Japanese) Kansenshogaku Zasshi 1986; 60: 1052-1077.
   Google Scholar
• Kobayashi H, Takamura K, Takeda H, et al. Comparative clinical study of ciprofloxacin and cefaclor in the treatment of respiratory tract infections. Chemotherapy 1986; 34: 1011-1037.
   Google Scholar
• Konno K, Oizumi K, Watanabe A, et al. Double blind comparative study on cefuroxime axetil vs cefaclor in bacterial respiratory tract infections. Chemotherapy 1987; 35: 435-461.
   Google Scholar
• Konno K, Saito A, Oizumi S, et al. Comparison of cefixime and cefaclor in bacterial bronchitis. Chemotherapy 1986; 34: 1150-1183.
   Google Scholar
• Law MR, Holt HA, Reeves DS, Hodson ME. Cefaclor and amoxycillin in the treatment of infective exacerbations of chronic bronchitis. J Antimicrob Chemother 1983; 11: 83-88.
   Google Scholar
• Lee GS, Kakati R, Mahmoud IA. A comparison of cefaclor and ampicillin in the treatment of respiratory infection in elderly in-patients. Curr Med Res Opin 1980; 6: 564-568.
   Google Scholar
• Leuenberger P, Vrantchev S. Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: a comparative double-blind study. Eur J Clin Microbiol 1983; 2: 11-16.
   Google Scholar
• Maniatis T, Castellano M. Comparative evaluation of cefaclor versus amoxicillin/clavulanate potassium in the treatment of bacterial bronchitis. Curr Ther Res - Clin Exp 1990; 48: 308-312.
   Google Scholar
• Matsumoto K, Saito A, Nagahama F, et al. A comparative clinical study of cefaclor and cephalexin in bacterial bronchitis. Chemotherapy 1981; 29: 653-697.
   Google Scholar
• McCabe R, Rumans L, Perrotta R, Mogabgab W. Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis. J Chemother 1993; 5: 124-132.
   Google Scholar
• Moreo G, Sardi C, Braschi R, Nani M, Remotti G. Comparison of an antibiotic combination (amoxicillin + clavulanic acid) and cefaclor in the treatment of acute or flare-ups of chronic bronchopneumopathies. <Confronto tra una associazione antibiotica (amoxicillina + acido clavulanico) e il cefaclor nel trattamento delle broncopneumopatie acute o croniche riacutizzate.> Clin Ter 1988; 126: 411-416.
   Google Scholar
• Notario G, Siepman N, Devcich K, Guay DRP. Comparative safety and efficacy of clarithromycin and three oral cephalosporins in the treatment of outpatients with bacterial bronchitis. Curr Ther Res - Clin Exp 1993; 54: 628-640.
   Google Scholar
• Oshima S, Yokoyama Y, Kikuiri T, et al. A double blind comparative study on the efficacy of S 6472, cefaclor in the treatment of bacterial bronchitis. Jpn J Antibiot 1986; 39: 2726-2753.
   Google Scholar
• Pariente R, Rochemaure J, Murciano D, Brechot JM, Pappo M. Treatment of lower respiratory tract infections with cefuroxime-axetil. Comparison with cefaclor. <Traitement des infections des voies aeriennes inferieures par le cefuroximeaxetil. Comparaison avec le cefaclor>. Therapie 1988; 43 Suppl 4: 361-364.
   Google Scholar
• Paupe J, Sarbeji M, Scheinmann P, Delacourt C, Sorin M. Clinical trial on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil. Chemotherapy 1992; 38 suppl 2: 29-32.
   Google Scholar
• Pelletier Jr LL. Cefprozil versus cefaclor in the treatment of bronchitis in the elderly. Drug Invest 1994; 8: 263-270.
   Google Scholar
• Perrotta R, McCabe R, Rumans L, Nolen T. Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of acute bacterial bronchitis. Infect Dis Clin Prac 1994; 3: 270-276.
   Google Scholar
• Phillips H, Van Hook CJ, Butler T, Todd WM. A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults. Chest 1993; 104: 1387-1392.
   Google Scholar
• Quenzer RW, Davis RL, Neidhart MM. Prospective randomized study comparing the efficacy and safety of ciprofloxacin with cefaclor in the treatment of patients with purulent bronchitis. Diagn Microbiol Infect Dis 1990; 13: 143-148.
   Google Scholar
• Saito A, Shigeno Y, Irabu Y, et al. Clinical evaluation of cefotiam hexetil in chronic respiratory tract infections. Double blind controlled trial using cefaclor as a positive control. Chemotherapy 1989; 37: 455-481.
   Google Scholar
• Saito A, Shigeno Y, Irabu Y, et al. Clinical evaluation of cefotiam hexetil in bacterial pneumonia: Double-blind controlled trial using cefaclor as a standard drug. Chemotherapy 1989; 37: 59-83.
   Google Scholar
• Schleupner CJ, Anthony WC, Tan J, et al. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections. Arch Intern Med 1988; 148: 343-348.
   Google Scholar
• Scott WG, Cooper BC, Scott HM, Tilyard MW, Dovey SM. Cost effectiveness of roxithromycin versus cefaclor in Australia. PharmacoEconomics 1995; 7: 93-94.
   Google Scholar
• Sevieri F. Efficacy and tolerability of cefaclor and amino clavulanic acid in the treatment of lower respiratory tract infections. <Studio sull’efficacia e la tollerabilita del cefaclor e della amoxicillina-acido clavulanico nel trattamento delle infezioni del tratto respiratorio inferiore.> Min Pneumol 1991; 30: 95-97.
   Google Scholar
• Sevieri G, Monacci A, Roggi G. Comparison between cefixime and cefaclor in the treatment of lower respiratory tract infections. <Cefixime e cefaclor nella terapia delle infezioni del tratto respiratorio inferiore: studio comparativo.> Min Pneumol 1993; 32: 37-41.
   Google Scholar
• Sevieri GF, Roggi G. Comparison between cefaclor and acetoxyethylcefuroxime in the treatment of respiratory infections. <Confronto fra cefaclor e acetoxietilcefuroxima nel trattamento delle infezioni respiratorie.> Min Pneumol 1991; 30: 163-166.
   Google Scholar
• Shiba K, Saito A, Shimada J, et al. Comparative clinical study of CS-807 and cefaclor in chronic respiratory tract infections by a double-blind method. (In Japanese) Kansenshogaku Zasshi 1988; 62: 1166-1191.
   Google Scholar
• Shiba K, Saito A, Shimada J, et al. Comparative clinical study of CS-807 and cefaclor for bacterial pneumonia by a double-blind method. (In Japanese) Kansenshogaku Zasshi 1988; 62: 973-1001.
   Google Scholar
• Shibaki H, Chimoto T, Nakabayashi T, et al. A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin in the treatment of bacterial pneumonia. Jpn J Antibiot 1986; 39: 853-886.
   Google Scholar
• Shimada K, Sano Y, Miyamoto Y, et al. Comparative study on the efficacy of lomefloxacin (NY-198) and cefaclor in respiratory tract infections. Chemotherapy 1989; 37: 616-645.
   Google Scholar
• Syrogiannopoulos GA, Haliotis FA, Beratis NG. The new oral cephalosporin cefetamet pivoxil in the treatment of childhood pneumonia. Curr Ther Res 1990; 47: 245-251.
   Google Scholar
• Syrogiannopoulos GA, Da Silva Chibante AM, Gatzola M, et al. Cefetamet pivoxil in the treatment of community-acquired pneumonia in children. Drug Invest 1994; 8: 31-37.
   Google Scholar
• Tilyard MW, Dovey SM. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice. Diagn Microbiol Infect Dis 1992; 15 suppl: 97-101.
   Google Scholar
• Trigg CJ, Wilks M, Herdman MJ, Clague JE, Tabaqchali S, Davies RJ. A double-blind comparison of the effects of cefaclor and amoxycillin on respiratory tract and oropharyngeal flora and clinical response in acute exacerbations of bronchitis. Respir Med 1991; 85: 301-308.
   Google Scholar
• Wettengel R, Vetter N, Waardenburg FA. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis. J Antimicrob Chemother 1993; 31: 963-972.
   Google Scholar
• Wilber RB, Hamilton H, Leroy A, et al. Cefprozil vs. cefaclor in the treatment of lower respiratory tract infections. Infect Med 1992; 9 suppl C: 44-55.
   Google Scholar
• Yangco BG, Lowe J, Nolen TM, Schleupner C, Tan JS, Anthony W. A multicenter trial comparing the efficacy and safety of cefuroxime axetil and cefaclor in pneumonia of adults. Clin Ther 1990; 12: 440-446.
   Google Scholar
• ZeLuff B, Catchpole M, Lowe P, et al. Cefadroxil compared with cefaclor in the treatment of streptococcal pneumonia in adults. Drugs 1986; 32 suppl. 3: 39-42.
   Google Scholar